High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis.

Bezieau, S; Devilder, M C; Avet-Loiseau, H; Mellerin, M P; Puthier, D; Pennarun, E; Rapp, M J; Harousseau, J L; Moisan, J P; Bataille, R

Bezieau, S; Devilder, M C; Avet-Loiseau, H; Mellerin, M P; Puthier, D; Pennarun, E; Rapp, M J; Harousseau, J L; Moisan, J P; Bataille, R.

Affiliation

Bezieau S; Laboratoire de Génétique Moléculaire, Institut de Biologie, Nantes, France.

Hum Mutat ; 18(3): 212-24, 2001 Sep.

Article in En | MEDLINE | ID: mdl-11524732

Subject(s)

Genes, ras/genetics; Leukemia, Plasma Cell/genetics; Multiple Myeloma/genetics; Alleles; Base Sequence; DNA Mutational Analysis; DNA, Neoplasm/chemistry; DNA, Neoplasm/genetics; Gene Frequency; Humans; Leukemia, Plasma Cell/diagnosis; Multiple Myeloma/diagnosis; Mutation; Polymerase Chain Reaction/methods; Tumor Cells, Cultured

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Leukemia, Plasma Cell / Genes, ras / Multiple Myeloma Type of study: Diagnostic_studies / Incidence_studies / Risk_factors_studies Limits: Humans Language: En Year: 2001 Type: Article

Search on Google

XML

PubMed Links